Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BGNE

BeiGene

$129.85

-8.77 (-6.33%)

05:22
04/15/19
04/15
05:22
04/15/19
05:22
Recommendations
BeiGene analyst commentary at Piper Jaffray »

BeiGene should be owned,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$145.78

0.97 (0.67%)

04:55
04/11/19
04/11
04:55
04/11/19
04:55
Conference/Events
BeiGene management to meet with Piper Jaffray »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

BGNE

BeiGene

$146.64

1.94 (1.34%)

06:53
04/05/19
04/05
06:53
04/05/19
06:53
Conference/Events
BeiGene management to meet with Piper Jaffray »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

BGNE

BeiGene

$138.01

6.03 (4.57%)

16:12
04/01/19
04/01
16:12
04/01/19
16:12
Hot Stocks
BeiGene presents Phase 1 tislelizumab data at AACR »

BeiGene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 04

    Apr

  • 11

    Apr

Over a month ago
BGNE

BeiGene

$134.66

-1.85 (-1.36%)

08:36
03/15/19
03/15
08:36
03/15/19
08:36
Initiation
BeiGene initiated at BofA/Merrill »

BeiGene initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

BGNE

BeiGene

$149.99

-1.86 (-1.22%)

07:11
03/06/19
03/06
07:11
03/06/19
07:11
Hot Stocks
BeiGene, Ambrx announce collaboration to develop biologics »

Ambrx and BeiGene…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$140.37

0.27 (0.19%)

05:16
02/28/19
02/28
05:16
02/28/19
05:16
Recommendations
BeiGene analyst commentary at Piper Jaffray »

BeiGene price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$140.37

0.27 (0.19%)

16:32
02/27/19
02/27
16:32
02/27/19
16:32
Earnings
BeiGene reports Q4 EPS ($4.52), consensus ($2.73) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

BGNE

BeiGene

$139.52

1.89 (1.37%)

17:05
02/25/19
02/25
17:05
02/25/19
17:05
Recommendations
BeiGene analyst commentary at Cowen »

BeiGene coverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

BGNE

BeiGene

$138.89

6.575 (4.97%)

16:33
02/19/19
02/19
16:33
02/19/19
16:33
Hot Stocks
BeiGene announces fist patient dosed in Phase 2 MAGNOLIA trial »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.